Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04526886 · OUTCOME

Relative Dose Intensity of Chemotherapy

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy · Source last updated 2025-10-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
Percentage
Interval / dispersion
Inter-Quartile Range
Time frame
Through day 1 of cycle 6 of FOLFOX chemotherapy (cycle length is 14 days)

What was measured

Relative dose intensity (RDI) of chemotherapy. RDI is defined as (planned cumulative dose/cumulative administered dose)\*(actual duration/planned duration). RDI will be calculated separately for each component of the FOLFOX regimen (5-FU bolus, 5-FU infusion, oxaliplatin).

Groups in this outcome

Participants Completing Six Cycles of FOLFOX

Participants completing six cycles of FOLFOX (evaluable population for relative dose intensity)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Participants Completing Six Cycles of FOLFOX45

Reported measurements

5-FU infusion
Values in Percentage · Interval/dispersion: Inter-Quartile Range
GroupValueSpreadLowerUpperComment
Participants Completing Six Cycles of FOLFOX0.913Not reported0.8751.00Not reported
Oxaliplatin
Values in Percentage · Interval/dispersion: Inter-Quartile Range
GroupValueSpreadLowerUpperComment
Participants Completing Six Cycles of FOLFOX0.850Not reported0.7890.968Not reported
5-FU bolus
Values in Percentage · Interval/dispersion: Inter-Quartile Range
GroupValueSpreadLowerUpperComment
Participants Completing Six Cycles of FOLFOX0.643Not reported0.4550.917Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.875
        upper Limit
        1.00
        value
        0.913
    title
    5-FU infusion
  2. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.789
        upper Limit
        0.968
        value
        0.850
    title
    Oxaliplatin
  3. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.455
        upper Limit
        0.917
        value
        0.643
    title
    5-FU bolus
denoms
  1. counts
    1. group Id
      OG000
      value
      45
    units
    Participants
description
Relative dose intensity (RDI) of chemotherapy. RDI is defined as (planned cumulative dose/cumulative administered dose)\*(actual duration/planned duration). RDI will be calculated separately for each component of the FOLFOX regimen (5-FU bolus, 5-FU infusion, oxaliplatin).
dispersion Type
Inter-Quartile Range
groups
  1. description
    Participants completing six cycles of FOLFOX (evaluable population for relative dose intensity)
    id
    OG000
    title
    Participants Completing Six Cycles of FOLFOX
param Type
MEAN
reporting Status
POSTED
time Frame
Through day 1 of cycle 6 of FOLFOX chemotherapy (cycle length is 14 days)
title
Relative Dose Intensity of Chemotherapy
type
SECONDARY
unit Of Measure
Percentage

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice